Parr Brown Gee & Loveless recently advised Merit Medical Systems Inc. in connection with its Rule 144A offering of $747.5 million in aggregate principal amount of its 3.00% senior notes due 2029 and the capped call transactions entered by Merit in connection with the offering. Merit intends to use the net proceeds from the offering to pay the cost of the capped call transactions and for general corporate purposes.
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit is determined to make a difference by understanding its customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world.
The Parr Brown team was led by shareholders Michael Schefer and Dane Johansen who were assisted by Abbey Farnsworth, Jordan Toone and Meg Krivanec.